Pyrimidine derivatives as kinase modulators and method of use

Details for Australian Patent Application No. 2005322855 (hide)

Owner Exelixis, Inc.

Inventors Mann, Lary W.; Leahy, James W.; Nuss, John; Epshteyn, Sergey; Schnepp, Kevin Luke; Noguchi, Robin Tammie; Chen, Jeff; Ibrahim, Mohamed Abdulkader; Dalrymple, Lisa Esther; Shi, Xian; Williams, Matthew Alan; Ridgway, Brian Hugh; Takeuchi, Craig Stacy; Huynh, Tai Phat; Mann, Grace; Sangalang, Joan Cruz; Cheung, Atwood K.; Forsyth, Timothy Patrick; Lewis, Gary Lee

Agent Davies Collison Cave

Pub. Number AU-B-2005322855

PCT Pub. Number WO2006/074057

Priority 60/640,439 30.12.04 US; 60/704,863 01.08.05 US

Filing date 28 December 2005

Wipo publication date 13 July 2006

Acceptance publication date 20 September 2012

International Classifications

C07D 403/14 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/42 - Oxazoles

A61K 31/495 - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 Antineoplastic agents

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 413/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

12 July 2007 PCT application entered the National Phase

  PCT publication WO2006/074057 Priority application(s): WO2006/074057

20 September 2012 Application Accepted

  Published as AU-B-2005322855

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005322869-Framework residue substituted humanized COL-1 antibodies and their use

2005322850-Local item extraction